These changes may reflect important decreases in the release of CD197 expressing cells from monocyte stored pools and a decline in migration of CD192 expressing monocytes out of the circulation perhaps due to the decline of MCP-1 plasma levels with SCD treatment (Table 2) [43]. The gene discussed is CCL2; the disease is Schnyder corneal dystrophy.